“We actively monitor our Focus List to revisit compelling ideas when risk/reward becomes favorable. This discipline drove both our decision to reinvest in Vishay Precision and to add BioLife Solutions ”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
